PILMA Letter of Opposition to 340B Expansion in New York. 

The Honorable Kathy Hochul Governor of New York New York State Capitol Building Albany, NY 12224 Dear Governor Hochul, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), I write to express strong opposition to the inclusion of 340B expansion language in the final New York State budget, including the language reflected in A.6222 (Paulin) […]

PILMA Letter on 340B Legislation in Minnesota

 February 25, 2026  Senator Erin Murphy 95 University Ave W Minnesota Senate Building, Room 3113 St. Paul, MN 55115  Representative Lisa Demuth C Centennial Office Building, 2nd Floor St. Paul, MN 55115  Dear Majority Leader Murphy and Speaker Demuth:  On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), a labor-management partnership representing unions and biopharmaceutical […]

PILMA Letter on Virginia PDAB Legislation

The Honorable Abigail Spanberger Governor of Virginia 1111 East Broad Street Richmond, VA 23219  Dear Governor Spanberger,  On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), we respectfully urge you to oppose HB 483 / SB 271, legislation that would establish a Prescription Drug Affordability Board.  We recognize that the cost of prescription drugs is […]

PILMA Letter to the Subcommittee on Health Hearing – “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain

February 11, 2025 The Honorable Brett Guthrie, Chairman House Committee on Energy and Commerce 2161 Rayburn House Office Building, Washington, DC 20515 The Honorable Representative Frank Pallone, Ranking Member House Committee on Energy and Commerce 2125 Rayburn House Office Building, Washington, DC 20515 Re: Subcommittee on Health Hearing – “Lowering Health Care Costs for All […]

PILMA Applauds Bipartisan PBM Reform in Congressional Appropriations Package

February 3, 2026 Washington, D.C. – The Pharmaceutical Industry Labor-Management Association (PILMA) applauds Congress for passing critical pharmacy benefit manager (PBM) reform legislation as part of the bipartisan spending package now headed to the President’s desk. “After years of advocacy, meaningful PBM reform has finally crossed the finish line,” said AJ Stokes, PILMA’s Executive Director. […]

PILMA Calls for PBM Reform in the 119th Congress

The Honorable Brett Guthrie, Chairman House Committee on Energy and Commerce 2161 Rayburn House Office Building, Washington, DC 20515  The Honorable Representative Frank Pallone, Ranking Member House Committee on Energy and Commerce 2125 Rayburn House Office Building, Washington, DC 20515  The Honorable Representative Jason Smith, Chairman House Committee on Ways and Means 1011 Longworth House Office Building, Washington, DC 20515  […]

PRESS RELEASE PILMA Applauds Bipartisan PBM Reform Legislation, Urges Swift Action Before Year’s End

December 5, 2025 FOR IMMEDIATE RELEASE PILMA Applauds Bipartisan PBM Reform Legislation, Urges Swift Action Before Year’s End Washington, D.C. – The Pharmaceutical Industry Labor-Management Association (PILMA) today applauded Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Ron Wyden (D-Oregon) for introducing the bipartisan Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act. […]

Senate HELP: PBM transparency and reform letter

December 3, 2025 The Honorable Bill Cassidy, ChairmanSenate Committee on Health, Education, Labor & Pensions428 Senate Dirksen Office Building, Washington, DC, 20510 The Honorable Bernie Sanders, Ranking MemberSenate Committee on Health, Education, Labor & Pensions428 Senate Dirksen Office Building, Washington, DC, 20510 Dear Senators Cassidy and Sanders, We write today on behalf of the Pharmaceutical […]

RESOLUTION Concerning Federal Permitting Reform

November 4, 2025 WHEREAS, the Pharmaceutical Industry Labor-Management Association (PILMA) is a coalition of labor unions and companies in the pharmaceutical industry united to grow the economy, create high-quality union jobs, and foster medical innovation; and WHEREAS, PILMA’s mission includes supporting policies that strengthen American infrastructure, and ensure the timely construction of projects that sustain […]